Quantbot Technologies LP boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 298.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 106,216 shares of the healthcare conglomerate’s stock after buying an additional 79,537 shares during the period. UnitedHealth Group accounts for about 1.8% of Quantbot Technologies LP’s investment portfolio, making the stock its 3rd largest position. Quantbot Technologies LP’s holdings in UnitedHealth Group were worth $17,420,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the stock. TNB Financial purchased a new stake in shares of UnitedHealth Group during the first quarter valued at approximately $249,000. Private Trust Co. NA raised its stake in shares of UnitedHealth Group by 58.3% in the first quarter. Private Trust Co. NA now owns 7,402 shares of the healthcare conglomerate’s stock valued at $1,214,000 after buying an additional 2,726 shares during the last quarter. Inverness Counsel LLC NY raised its stake in shares of UnitedHealth Group by 16.5% in the first quarter. Inverness Counsel LLC NY now owns 213,701 shares of the healthcare conglomerate’s stock valued at $35,380,000 after buying an additional 30,330 shares during the last quarter. Prospera Financial Services Inc raised its stake in shares of UnitedHealth Group by 23.8% in the first quarter. Prospera Financial Services Inc now owns 4,528 shares of the healthcare conglomerate’s stock valued at $745,000 after buying an additional 871 shares during the last quarter. Finally, Private Bank & Trust Co. raised its stake in shares of UnitedHealth Group by 8.5% in the first quarter. Private Bank & Trust Co. now owns 9,860 shares of the healthcare conglomerate’s stock valued at $1,618,000 after buying an additional 770 shares during the last quarter. Institutional investors own 86.21% of the company’s stock.

UnitedHealth Group Incorporated (UNH) traded down 0.20% during trading on Friday, reaching $194.36. 1,374,959 shares of the company were exchanged. The firm has a 50-day moving average of $191.39 and a 200-day moving average of $177.02. UnitedHealth Group Incorporated has a 52-week low of $132.39 and a 52-week high of $196.04. The firm has a market cap of $187.92 billion, a price-to-earnings ratio of 23.35 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, beating the consensus estimate of $2.38 by $0.08. The company had revenue of $50.05 billion during the quarter, compared to analyst estimates of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. UnitedHealth Group’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.96 EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post $9.87 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th will be paid a $0.75 dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $3.00 annualized dividend and a dividend yield of 1.54%. UnitedHealth Group’s dividend payout ratio is currently 35.13%.

COPYRIGHT VIOLATION NOTICE: “Quantbot Technologies LP Has $17.42 Million Position in UnitedHealth Group Incorporated (UNH)” was originally published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this story on another website, it was illegally stolen and reposted in violation of United States and international copyright law. The correct version of this story can be accessed at https://theolympiareport.com/2017/08/27/quantbot-technologies-lp-has-17-42-million-position-in-unitedhealth-group-incorporated-unh.html.

UNH has been the topic of several analyst reports. Vetr upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $179.00 price target on the stock in a research note on Monday, May 15th. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Friday, May 19th. Jefferies Group LLC reiterated a “buy” rating and set a $192.00 price objective on shares of UnitedHealth Group in a research note on Friday, May 19th. Finally, Morgan Stanley started coverage on shares of UnitedHealth Group in a research note on Tuesday, June 6th. They set an “overweight” rating and a $202.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating and twenty-four have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $203.41.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $182.64, for a total value of $913,200.00. Following the completion of the sale, the director now owns 75,735 shares in the company, valued at approximately $13,832,240.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction on Monday, August 21st. The shares were sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the sale, the director now owns 1,818,898 shares of the company’s stock, valued at approximately $348,700,935.58. The disclosure for this sale can be found here. Insiders sold a total of 30,540 shares of company stock valued at $5,748,970 in the last quarter. 0.89% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.